What’s the Problem?
According to an FDA Recall Notice dated 6/11/20, this action affects Lupin Metformin Hydrochloride Extended-Release Tablets USP (generic equivalent of Fortamet®), 500mg, lot G901203.
FDA testing revealed levels of N-Nitrosodimethylamine (NDMA) that exceeded the Acceptable Daily Intake Limit (ADI) of 96ng/day, the agency said. Exposure to high doses of NDMA has been linked to:
- Prostate cancer
- Lower esophageal cancer
- Non-hodgkin lymphoma
- Multiple myeloma
- Colon cancer
- Stomach cancer
- Intestinal cancer
- Pancreatic cancer
- Liver failure
Consumers who were prescribed any metformin that is affected by this recall should contact Lupin Pharmaceuticals for a return/replacement. Anyone concerned about an adverse reaction to NDMA in metformin should call their doctor, FDA said.
Do I Have a Lupin Metformin Recall Class Action Lawsuit?
The Pharmaceutical Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Lupin Metformin Recall Class Action Lawsuits. We are handling individual litigation nationwide and currently accepting new injury and death cases in all 50 states.
If you or a loved one was diagnosed with cancer after taking recalled metformin, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.